Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study. Narita I, Hayashi T, Maruyama S, Masaki T, et al. PLoS One 2022;17:e0277921.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Narita I, Hayashi T, Maruyama S, Masaki T, et al. Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study. PLoS One 2022;17:e0277921.
PMID: 36445882